Teva Pharmaceutical Industries Presents Final Analysis of PEARL Study Demonstrating Sustained Effectiveness of AJOVY in Migraine Prevention at EAN 2025 Congress
23/6 09:10
The PEARL study confirms fremanezumab's long-term effectiveness and safety in migraine prevention over two years....